LifeStance Health GroupLFST +3.58%56 Debt-to-Equity is 0.31 as of Mar. 2026, which is at its 10-year median of 0.31. GuruFocus rates LFST with a GF Score™ of 56/100 and a GF Value™ of $8.23 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 557 Healthcare Providers & Services companies, LifeStance Health Group ranks better than 57.45% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for LifeStance Health Group's Debt-to-Equity or its related term are showing as below:
LFST'
s Debt-to-Equity Range Over the Past 10 Years
Min: -0.48 Med: 0.31 Max: 0.41
Current: 0.31
During the past 7 years, the highest Debt-to-Equity Ratio of LifeStance Health Group was 0.41. The lowest was -0.48. And the median was 0.31.
LFST's Debt-to-Equity is ranked better than 57.45% of 557
companies
in the Healthcare Providers & Services industry
Industry Median: 0.4
vs LFST: 0.31
LifeStance Health Group (NAS:LFST) Debt-to-Equity Explanation
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
LifeStance Health Group Debt-to-Equity Related Terms
LifeStance Health Group Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, LifeStance Health Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group (LFST) has a Debt-to-Equity of 0.31 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on LifeStance Health Group and its competitors. This is near median its historical median of 0.31. According to the industry distribution chart, LifeStance Health Group ranks #237 out of 557 companies in the Healthcare Providers & Services industry, placing it in the top 42.5%.
Is LifeStance Health Group's Debt-to-Equity too high?
LifeStance Health Group's current Debt-to-Equity of 0.31 is near median its 10-year median of 0.31. The Healthcare Providers & Services industry median Debt-to-Equity is 0.40. LifeStance Health Group's value of 0.31 is 22.5% below this industry median. Based on the distribution chart, LifeStance Health Group ranks #237 out of 557 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, LifeStance Health Group has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Debt-to-Equity compare to CON and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #237 out of 557 companies for Debt-to-Equity. This puts LifeStance Health Group in the upper half of its industry. The industry median Debt-to-Equity is 0.40. LifeStance Health Group's value of 0.31 is 22.5% below this benchmark. While the company's 10-year median is 0.31 vs. the industry median of 0.40, LifeStance Health Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.40, based on 557 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current Debt-to-Equity of 0.31 is 22.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on LifeStance Health Group and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current Debt-to-Equity is 0.31, which is near median its own 10-year median of 0.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.23, compared to a current price of $10.72 — trading 30.3% above its estimated fair value. The current Debt-to-Equity is 0.31, which is near median its 10-year median of 0.31 and 22.5% below the Healthcare Providers & Services industry median of 0.40. LifeStance Health Group's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Debt-to-Equity is 0.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $10.72 is trading 30.3% above its estimated GF Value™ of $8.23.
GuruFocus considers LifeStance Health Group to be Modestly Overvalued.
Key valuation signals for LFST:
Debt-to-Equity: 0.31 (near median its 10-year median of 0.31)
GF Value™: $8.23 vs. price of $10.72 (30.3% above fair value)
Industry Position: 22.5% below the Healthcare Providers & Services median (#237 of 557)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
56GF Score
Get the complete analysis for LFST
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
